UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 4 Quality Education
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Kuo-Chu Lai
- Department of Pharmocology - Associate Professor
- Division of Physiology and Pharmacology - Associate Professor
Person
-
Yunn-Hwa Ma
- Department of Pharmocology - Professor
- Division of Physiology and Pharmacology - Professor
Person
-
Kang-Yung Peng
- Department of Pharmocology - Assistant Research Fellow
- Division of Physiology and Pharmacology - Assistant Research Fellow
Person
-
Establishment of Translational Precision Medicine for Early Detection of Advanced Head and Neck Cancer: from Animal Model to Clinic
Lai, K.-C. (PI) & Hsieh, C. H. (CoPI)
01/08/25 → 31/07/26
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Pegylated Nanocomposite-Induced Acute Hypersensitivity Reaction: Mechanism and Prevention( I )
Ma, Y.-H. (PI), Shen, C.-R. (CoPI) & Yeh, C.-H. (CoPI)
01/08/25 → 31/07/26
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Investigating the Drug-Nutrient Interaction of Bioactive Compounds in Dietary Supplements Mediated by the Atp-Binding Cassette Transporters
Wu, C.-P. (PI) & Hung, T.-H. (CoPI)
01/08/25 → 31/07/26
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
Research output
-
Befotertinib restored chemosensitivity to multidrug-resistant cancer cells by inhibiting the drug efflux activity of ABCB
Li, Y. C., Murakami, M., Huang, Y. H., Wu, Y. S., Hung, T. H., Ambudkar, S. V. & Wu, C. P., 01 03 2026, In: Journal of Pharmacy and Pharmacology. 78, 3, rgag020.Research output: Contribution to journal › Journal Article › peer-review
-
Erratum to "The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs" [European Journal of Pharmaceutical Sciences (2025) 107337]
Li, Y. C., Lin, B. H., Murakami, M., Wu, Y. S., Hung, T. H., Ambudkar, S. V. & Wu, C. P., 01 01 2026, In: European Journal of Pharmaceutical Sciences. 216, p. 107384 107384.Research output: Contribution to journal › Comment/debate
Open Access -
IL-6 as a driver of bone invasion in IFIT2-depleted oral squamous cell carcinoma
Lai, K. C., Hsieh, C. H., Wang, C. H., Hsiao, S. Y., Kao, W. C., Chao, C. C. & Chen, P. C., 31 01 2026, In: Cancer Immunology, Immunotherapy. 75, 2, p. 64 64.Research output: Contribution to journal › Journal Article › peer-review
Open Access
Activities
- 7 Participating in a conference, workshop, ...
-
International Conference on Innovations in Pharma R&D
Ma, Y.-H. (Participant)
03 11 2025 → 05 11 2025Activity: Participating in or organizing an event › Participating in a conference, workshop, ...
-
11th International Conference on Advanced Materials and Nanotechnology
Ma, Y.-H. (Participant)
09 02 2025 → 13 02 2025Activity: Participating in or organizing an event › Participating in a conference, workshop, ...
-
14th International Conference on the Scientific and Clinical Applications of Magnetic Carriers
Ma, Y.-H. (Participant)
17 06 2024 → 21 06 2024Activity: Participating in or organizing an event › Participating in a conference, workshop, ...
Prizes
-
2024 World's Top 2% Scientists- Single-year Impact
Wu, C.-P. (Recipient), 2024
Prize: World's Top 2% Scientists › World's Top 2% Scientists:Single-year Impact
-
2025 World's Top 2% Scientists-Single-year Impact
Wu, C.-P. (Recipient), 2025
Prize: World's Top 2% Scientists › World's Top 2% Scientists:Single-year Impact